2e92f6cf200824c760c3dbdb3fcf0775 303897.pdf dc35e682f227ba420630dad385ca81b4c7ba95e0 303897.pdf 5b54c96ea89e7015f4fb5d30eb88519cd590c43d936963a7291ba4fe13ad07dc 303897.pdf Title: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes Subject: Objective: Patients with psoriasis have an increased prevalence of type 2 diabetes when compared to the general population. Keywords: moderate-to-severe psoriasis, type 2 diabetes, prediabetes, ixekizumab, obesity Author: Alexander Egeberg Creator: LaTeX with hyperref package + hypdvips Producer: dvips + MiKTeX GPL Ghostscript 9.0 CreationDate: Tue Mar 7 15:26:03 2023 CET ModDate: Wed Mar 8 07:27:59 2023 CET Custom Metadata: no Metadata Stream: yes Tagged: no UserProperties: no Suspects: no Form: none JavaScript: no Pages: 8 Encrypted: no Page size: 595.26 x 842.116 pts (A4) Page rot: 0 File size: 457988 bytes Optimized: no PDF version: 1.4 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- NENOJK+MuseoSans-300 Type 1C Custom yes yes yes 32 0 HCWXZM+MuseoSans-700 Type 1C Custom yes yes yes 29 0 AXEUZI+MTSY Type 1C Custom yes yes no 58 0 SHAWFQ+MuseoSans-500 Type 1C Custom yes yes yes 55 0 IMGWIL+MinionPro-Regular Type 1C Custom yes yes no 48 0 GUMCEP+MuseoSans-300Italic Type 1C WinAnsi yes yes no 45 0 RQBMRA+MinionPro-It Type 1C WinAnsi yes yes no 85 0 GBAUGV+RMTMI Type 1C WinAnsi yes yes no 105 0 MSGNYE+MinionPro-BoldIt Type 1C WinAnsi yes yes no 103 0 TOPIXI+MinionPro-Bold Type 1C WinAnsi yes yes no 101 0 ICZSDK+MuseoSans-500Italic Type 1C WinAnsi yes yes no 99 0 USWLLE+MuseoSans-700Italic Type 1C WinAnsi yes yes no 97 0 Jhove (Rel. 1.28.0, 2023-05-18) Date: 2024-12-18 02:51:10 CET RepresentationInformation: 303897.pdf ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16) LastModified: 2024-12-17 08:27:39 CET Size: 457988 Format: PDF Version: 1.4 Status: Well-Formed and valid SignatureMatches: PDF-hul MIMEtype: application/pdf PDFMetadata: Objects: 210 FreeObjects: 1 IncrementalUpdates: 1 DocumentCatalog: ViewerPreferences: HideToolbar: false HideMenubar: false HideWindowUI: false FitWindow: true CenterWindow: false DisplayDocTitle: false NonFullScreenPageMode: UseNone Direction: L2R ViewArea: CropBox ViewClip: CropBox PrintArea: CropBox PageClip: CropBox PageLayout: SinglePage PageMode: UseOutlines Language: en Outlines: Item: Title: ぅててどっちっべ〠はて〠どへづにどぺふねちぢ〠どの〠ばちぴどづのぴび〠ぷどぴと〠ねはつづひちぴづ〭ぴは〭びづぶづひづ〠ばぬちぱふづ〠ばびはひどちびどび〠ちのつ〠ばひづつどちぢづぴづび〠はひ〠ぴべばづ〠〲〠つどちぢづぴづび Destination: ariclecounter.1 Children: Item: Title: ぉのぴひはつふっぴどはの Destination: section*.2 Item: Title: きづぴとはつび Destination: section*.3 Item: Title: げづびふぬぴび Destination: section*.4 Children: Item: Title: あちびづぬどのづ〠っとちひちっぴづひどびぴどっび Destination: section*.5 Item: Title: ぅててどっちっべ〠はふぴっはねづび Destination: section*.6 Item: Title: ぃぬどのどっちぬ〠ねづちびふひづび〠ちのつ〠ねづぴちぢはぬどっ〠ねちひにづひび Destination: section*.7 Item: Title: いどびっふびびどはの Destination: section*.8 Item: Title: ぃはのっぬふびどはの Destination: section*.9 Item: Title: いちぴち〠ちぶちどぬちぢどぬどぴべ〠びぴちぴづねづのぴ Destination: section*.10 Item: Title: ぅぴとどっび〠びぴちぴづねづのぴ Destination: section*.11 Item: Title: ぁふぴとはひ〠っはのぴひどぢふぴどはのび Destination: section*.12 Item: Title: うふのつどので Destination: section*.13 Item: Title: ぃはのてぬどっぴ〠はて〠どのぴづひづびぴ Destination: section*.14 Item: Title: ぐふぢぬどびとづひ〧び〠のはぴづ Destination: section*.15 Item: Title: げづてづひづのっづび Destination: section*.16 Info: Title: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes Author: Alexander Egeberg Subject: Objective: Patients with psoriasis have an increased prevalence of type 2 diabetes when compared to the general population. Keywords: moderate-to-severe psoriasis, type 2 diabetes, prediabetes, ixekizumab, obesity Creator: LaTeX with hyperref package + hypdvips Producer: dvips + MiKTeX GPL Ghostscript 9.0 CreationDate: Tue Mar 07 15:56:03 CET 2023 ModDate: Wed Mar 08 07:57:59 CET 2023 ID: 0x7fffba5d33d60a9e90e1df7823ff6109, 0xc333b431bc6bb148bb0ab832b8362551 Filters: FilterPipeline: FlateDecode FilterPipeline: DCTDecode Images: Image: NisoImageMetadata: FormatName: image/png ImageWidth: 32 ImageHeight: 128 ColorSpace: RGB BitsPerSample: 8 BitsPerSampleUnit: integer Filter: FlateDecode Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1772 ImageHeight: 1875 BitsPerSample: 8 BitsPerSampleUnit: integer Interpolate: true Fonts: Type1: Font: BaseFont: NENOJK+MuseoSans-300 FontSubset: true FirstChar: 0 LastChar: 252 FontDescriptor: FontName: NENOJK+MuseoSans-300 Flags: Symbolic FontBBox: -55, -210, 890, 742 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: IMGWIL+MinionPro-Regular FontSubset: true FirstChar: 2 LastChar: 248 FontDescriptor: FontName: IMGWIL+MinionPro-Regular Flags: Symbolic FontBBox: -26, -257, 956, 713 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true Font: BaseFont: USWLLE+MuseoSans-700Italic FontSubset: true FirstChar: 45 LastChar: 116 FontDescriptor: FontName: USWLLE+MuseoSans-700Italic Flags: Nonsymbolic FontBBox: -53, -200, 586, 710 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: ICZSDK+MuseoSans-500Italic FontSubset: true FirstChar: 78 LastChar: 110 FontDescriptor: FontName: ICZSDK+MuseoSans-500Italic Flags: Nonsymbolic, SmallCap FontBBox: -53, 0, 734, 706 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: RQBMRA+MinionPro-It FontSubset: true FirstChar: 40 LastChar: 120 FontDescriptor: FontName: RQBMRA+MinionPro-It Flags: Serif, Nonsymbolic FontBBox: -67, -257, 903, 712 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: TOPIXI+MinionPro-Bold FontSubset: true FirstChar: 37 LastChar: 121 FontDescriptor: FontName: TOPIXI+MinionPro-Bold Flags: Nonsymbolic FontBBox: -8, -245, 969, 714 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: SHAWFQ+MuseoSans-500 FontSubset: true FirstChar: 3 LastChar: 228 FontDescriptor: FontName: SHAWFQ+MuseoSans-500 Flags: Symbolic FontBBox: 2, -210, 916, 744 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: MSGNYE+MinionPro-BoldIt FontSubset: true FirstChar: 110 LastChar: 110 FontDescriptor: FontName: MSGNYE+MinionPro-BoldIt Flags: Nonsymbolic, SmallCap FontBBox: 0, -12, 523, 700 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: GBAUGV+RMTMI FontSubset: true FirstChar: 60 LastChar: 60 FontDescriptor: FontName: GBAUGV+RMTMI Flags: Nonsymbolic, AllCap FontBBox: 0, 0, 682, 455 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: AXEUZI+MTSY FontSubset: true FirstChar: 6 LastChar: 68 FontDescriptor: FontName: AXEUZI+MTSY Flags: Symbolic FontBBox: 0, -133, 724, 668 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true Font: BaseFont: GUMCEP+MuseoSans-300Italic FontSubset: true FirstChar: 46 LastChar: 116 FontDescriptor: FontName: GUMCEP+MuseoSans-300Italic Flags: Nonsymbolic FontBBox: -53, -200, 796, 703 FontFile3: true Encoding: WinAnsiEncoding Font: BaseFont: HCWXZM+MuseoSans-700 FontSubset: true FirstChar: 40 LastChar: 122 FontDescriptor: FontName: HCWXZM+MuseoSans-700 Flags: Symbolic FontBBox: -55, -210, 941, 741 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true XMP: dvips + MiKTeX GPL Ghostscript 9.0 moderate-to-severe psoriasis, type 2 diabetes, prediabetes, ixekizumab, obesity 2023-03-08T11:57:59+05:30 2023-03-07T19:56:03+05:30 LaTeX with hyperref package + hypdvips 2023-03-08T11:57:59+05:30 7d493ca7-bf4f-11ed-0000-0c2d4a29b4eb uuid:7129575d-2f05-49c6-89a8-398280be3421 application/pdf Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes Alexander Egeberg Joseph F. Merola Knut Schäkel Luis Puig Patrick D. Mahar Isabella Yali Wang Imre Pavo Christopher Schuster Christopher E. M. Griffiths Objective: Patients with psoriasis have an increased prevalence of type 2 diabetes when compared to the general population. Objective: Patients with psoriasis have an increased prevalence of type 2 diabetes when compared to the general population. moderate-to-severe psoriasis type 2 diabetes prediabetes ixekizumab obesity Pages: Page: Label: 1 Annotations: Annotation: Subtype: Link Rect: 55, 781, 225, 798 Annotation: Subtype: Link Rect: 449, 792, 520, 800 Annotation: Subtype: Link Rect: 466, 783, 476, 791 Annotation: Subtype: Link Rect: 475, 783, 503, 791 Annotation: Subtype: Link Rect: 502, 783, 520, 791 Annotation: Subtype: Link Rect: 446, 774, 539, 783 Annotation: Subtype: Link Rect: 55, 690, 131, 707 Annotation: Subtype: Link Rect: 63, 532, 191, 540 Annotation: Subtype: Link Rect: 69, 367, 163, 374 Annotation: Subtype: Link Rect: 55, 308, 83, 315 Annotation: Subtype: Link Rect: 83, 308, 119, 315 Annotation: Subtype: Link Rect: 119, 308, 155, 315 Annotation: Subtype: Link Rect: 155, 308, 181, 315 Annotation: Subtype: Link Rect: 55, 299, 82, 306 Annotation: Subtype: Link Rect: 221, 590, 539, 707 Annotation: Subtype: Link Rect: 55, 43, 124, 50 Annotation: Subtype: Link Rect: 491, 41, 539, 50 Page: Label: 2 Sequence: 2 Annotations: Annotation: Subtype: Link Rect: 444, 792, 539, 799 Annotation: Subtype: Link Rect: 235, 579, 241, 592 Destination: External Annotation: Subtype: Link Rect: 244, 579, 250, 592 Destination: External Annotation: Subtype: Link Rect: 149, 529, 155, 542 Destination: External Annotation: Subtype: Link Rect: 275, 492, 282, 504 Destination: External Annotation: Subtype: Link Rect: 107, 430, 113, 442 Destination: External Annotation: Subtype: Link Rect: 115, 430, 121, 442 Destination: External Annotation: Subtype: Link Rect: 157, 380, 164, 392 Destination: External Annotation: Subtype: Link Rect: 58, 343, 65, 355 Destination: External Annotation: Subtype: Link Rect: 76, 343, 82, 355 Destination: External Annotation: Subtype: Link Rect: 198, 293, 204, 305 Destination: External Annotation: Subtype: Link Rect: 210, 293, 221, 305 Destination: External Annotation: Subtype: Link Rect: 94, 243, 104, 255 Destination: External Annotation: Subtype: Link Rect: 58, 118, 65, 131 Destination: External Annotation: Subtype: Link Rect: 67, 118, 77, 131 Destination: External Annotation: Subtype: Link Rect: 311, 543, 321, 555 Destination: External Annotation: Subtype: Link Rect: 365, 218, 393, 227 Destination: External Annotation: Subtype: Link Rect: 55, 42, 124, 49 Annotation: Subtype: Link Rect: 491, 40, 539, 49 Page: Label: 3 Sequence: 3 Annotations: Annotation: Subtype: Link Rect: 444, 792, 539, 799 Annotation: Subtype: Link Rect: 178, 160, 219, 171 Destination: External Annotation: Subtype: Link Rect: 224, 163, 232, 170 Destination: External Annotation: Subtype: Link Rect: 58, 98, 96, 108 Destination: External Annotation: Subtype: Link Rect: 475, 212, 503, 221 Destination: External Annotation: Subtype: Link Rect: 366, 100, 394, 109 Destination: External Annotation: Subtype: Link Rect: 55, 43, 124, 50 Annotation: Subtype: Link Rect: 491, 41, 539, 50 Page: Label: 4 Sequence: 4 Annotations: Annotation: Subtype: Link Rect: 444, 792, 539, 799 Annotation: Subtype: Link Rect: 140, 170, 150, 182 Destination: External Annotation: Subtype: Link Rect: 507, 95, 513, 107 Destination: External Annotation: Subtype: Link Rect: 515, 95, 521, 107 Destination: External Annotation: Subtype: Link Rect: 523, 95, 534, 107 Destination: External Annotation: Subtype: Link Rect: 55, 43, 124, 50 Annotation: Subtype: Link Rect: 491, 41, 539, 50 Page: Label: 5 Sequence: 5 Annotations: Annotation: Subtype: Link Rect: 444, 792, 539, 799 Annotation: Subtype: Link Rect: 55, 43, 124, 50 Annotation: Subtype: Link Rect: 491, 41, 539, 50 Page: Label: 6 Sequence: 6 Annotations: Annotation: Subtype: Link Rect: 444, 792, 539, 799 Annotation: Subtype: Link Rect: 117, 479, 123, 492 Destination: External Annotation: Subtype: Link Rect: 126, 479, 136, 492 Destination: External Annotation: Subtype: Link Rect: 271, 430, 282, 442 Destination: External Annotation: Subtype: Link Rect: 318, 235, 370, 246 Annotation: Subtype: Link Rect: 348, 222, 400, 233 Annotation: Subtype: Link Rect: 55, 43, 124, 50 Annotation: Subtype: Link Rect: 491, 41, 539, 50 Page: Label: 7 Sequence: 7 Annotations: Annotation: Subtype: Link Rect: 444, 792, 539, 799 Annotation: Subtype: Link Rect: 288, 255, 54, 273 Annotation: Subtype: Link Rect: 288, 220, 54, 238 Annotation: Subtype: Link Rect: 288, 191, 54, 210 Annotation: Subtype: Link Rect: 288, 147, 54, 166 Annotation: Subtype: Link Rect: 288, 111, 54, 130 Annotation: Subtype: Link Rect: 540, 271, 306, 289 Annotation: Subtype: Link Rect: 540, 236, 306, 253 Annotation: Subtype: Link Rect: 540, 200, 306, 217 Annotation: Subtype: Link Rect: 540, 164, 306, 181 Annotation: Subtype: Link Rect: 540, 120, 306, 138 Annotation: Subtype: Link Rect: 352, 92, 443, 101 Annotation: Subtype: Link Rect: 55, 42, 124, 49 Annotation: Subtype: Link Rect: 491, 40, 539, 49 Page: Label: 8 Sequence: 8 Annotations: Annotation: Subtype: Link Rect: 444, 792, 539, 799 Annotation: Subtype: Link Rect: 99, 716, 156, 725 Annotation: Subtype: Link Rect: 288, 679, 54, 698 Annotation: Subtype: Link Rect: 77, 648, 160, 655 Annotation: Subtype: Link Rect: 540, 699, 306, 718 Annotation: Subtype: Link Rect: 540, 646, 306, 664 Annotation: Subtype: Link Rect: 55, 43, 124, 50 Annotation: Subtype: Link Rect: 491, 41, 539, 50 Checksum: a27dded6 Type: CRC32 Checksum: 2e92f6cf200824c760c3dbdb3fcf0775 Type: MD5 Checksum: dc35e682f227ba420630dad385ca81b4c7ba95e0 Type: SHA-1 Checksum: 5b54c96ea89e7015f4fb5d30eb88519cd590c43d936963a7291ba4fe13ad07dc Type: SHA-256